Stories by PRNEWS

Terry Catchpole, founder and president of The Catchpole Corporation, a boutique PR firm specializing in securing speaking engagements for high-tech business executives, thinks the dot-com debacle was a blessing in disguise for niche PR. Huh?… Continued

They were started a few years ago by political observers who made their running commentaries available online, but have recently emerged as a potent media force for PR execs: blogs. These days, blogs go well… Continued

Massive forests were felled within the last week to report the guilty verdict in the Martha Stewart saga. With stories covering every conceivable angle of the case — ranging from how much time Stewart may… Continued

PR NEWS’ annual “15 to Watch” issue, which profiles dynamic PR execs who are 30 years old and under, is right around the corner. Please go to www.PRandMarketing.com for the nominating form. Deadline is March… Continued

Falco, the celluloid press agent, boasts early in the classic film “Sweet Smell of Success” (1957) that for one of his clients he’ll run the 50-yard dash “with both my legs cut off.” It’s a… Continued

Led by Debra Cabral, an executive VP for the past six years, the group will help not-for-profit organizations enhance their role and influence in public policy via messaging, media outreach, grass-roots, Internet and public education… Continued

Wherever they come from, CEOs and other decision-makers are turning into regular Webheads, according to a recently released survey conducted by Mindshare Internet Campaigns LLC with readers of NYTimes.com. Nearly all of the respondents, working… Continued

Coca-Cola directors have reportedly launched the company’s first-ever outside search for a CEO. But the soda king may want to stick to its old formula of hiring from within. A study released last week by… Continued

If practitioners had a crystal ball to understand how successful a public relations program would be, what would that be worth to the practitioner? Well, send your check my way as a new term and… Continued

Show me the money? Not anymore, at least not according to the team that put together the 2002 annual report for pharmaceutical giant Pfizer. While the traditional annual report has focused on bottom-line returns, Pfizer… Continued